Navigation Links
Savient Pharmaceuticals Reports First Quarter 2009 Financial Results
Date:5/6/2009

550 547 Additional paid in capital 216,831 214,467 Accumulated deficit (173,563) (151,614) Accumulated other comprehensive income 276 24 Total stockholders' equity 44,094 63,424 Total liabilities and stockholders' equity $76,983 $98,222 SAVIENT PHARMACEUTICALS, INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) (In thousands, except per share data) Three Months Ended March 31, 2009 2008 Revenues: Product sales, net $1,085 $1,144 Other revenues 3 44 1,088 1,188 Cost and expenses: Cost of goods sold 491 333 Research and development 12,763 11,161 Selling, general and administrative 9,468 9,264 22,722 20,758 Operating loss (21,634) (19,570) Investment income (expense), net (202) 953 Other expense, net (113) (150) Loss before income taxes (21,949) (18,767) Income tax benefit - (1,215) Net loss $(21,949) $(17,552) Loss per common share:
'/>"/>
SOURCE Savient Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Savient Pharmaceuticals to Hold Third Quarter 2008 Financial Results Conference Call on Thursday, November 6, 2008
2. Savients Pegloticase Data in Treatment-Failure Gout Patients Presented at 72nd Annual Meeting of the American College of Rheumatology Conference
3. Savient Submits Biologics License Application (BLA) for pegloticase
4. Savient Pharmaceuticals Reports Third Quarter 2008 Financial Results
5. Savient Pharmaceuticals to Present at the Lazard Capital Markets 5th Annual Healthcare Conference on November 18th
6. Savient Announces Appointment of David Gionco as Chief Financial Officer
7. Savient Pharmaceuticals to Hold Fourth Quarter and Year-End 2008 Results Conference Call on Thursday, February 26, 2009
8. Savient Pharmaceuticals to Raise $31 Million Through Registered Direct Offering
9. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
10. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
11. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... May 23, 2013 Pusan National University ... private biotherapeutics and contract research company focused on ... cancer, announced today a publication reporting the induction ... the oncolytic and immunotherapeutic vaccinia JX-594 (pexastimogene devacirepvec; ... published in the May 15 th , 2013 ...
(Date:5/23/2013)... May 23, 2013 Watlow®, an ... complete thermal systems, recently introduced its new catalog, ... of experience in designing and manufacturing industrial heaters, ... products to serve diverse customer needs. , A ... at the beginning of the book. These options ...
(Date:5/22/2013)... 2013 iLuv Creative Technology, the premier ... the mobile lifestyle, announces they are now shipping MultiCharger-X, ... multiple iPad devices efficiently. Winner of the 2013 internationally ... Design award, MultiCharger-X is revolutionizing the way businesses, schools, ... deployed. , MultiCharger-X (iAD910) combines the ...
(Date:5/22/2013)... 22, 2013  Superior Controls, Inc. has been ... Business NH Magazine.  For the past 22 years, ... distinguish themselves with extraordinary business and civic excellence. ... this honor," said Rick Pierro ... recognition, this award is a reflection of Superior ...
Breaking Biology Technology:Pusan National University Announces Science Translational Medicine Publication Highlighting Landmark Demonstration of Functional Anti-Cancer Antibody Induction in Patients Following JX-594 Treatment 2Pusan National University Announces Science Translational Medicine Publication Highlighting Landmark Demonstration of Functional Anti-Cancer Antibody Induction in Patients Following JX-594 Treatment 3Watlow Introduces Its New Industrial Heater Catalog 2iLuv Now Shipping the All New MultiCharger-X 2iLuv Now Shipping the All New MultiCharger-X 3Superior Controls of Seabrook, NH named Business of the Year for 2013 by Business NH Magazine 2
... HOUSTON -- Dec. 17, 2007 -- Using the latest ... physicists has discovered a surprising new electronic property in ... Earth -- lodestone, also known as magnetite. , By ... to get magnetite at temperatures colder than minus 250 ...
... Angiotech Pharmaceuticals,Inc. (NASDAQ: ANPI , TSX: ANP), ... announced that it has submitted a 510(k),application to ... its,innovative, anti-infective 5-Fluorouracil-coated (5-FU) Central Venous,Catheter (CVC)., ... a 510(k) application to,the FDA for our 5-FU ...
... ... Delivery Fleet, LONG ISLAND CITY, N.Y., Dec. 17 FreshDirect, ... today,announced that it has signed a contract with Tri-State Biodiesel to ... of 150 delivery trucks will start the switch to B5, a,blend ...
Cached Biology Technology:New property found in ancient mineral lodestone 2Angiotech Submits 510(K) To FDA For Its Innovative 5-FU CVC 2Angiotech Submits 510(K) To FDA For Its Innovative 5-FU CVC 3Angiotech Submits 510(K) To FDA For Its Innovative 5-FU CVC 4Angiotech Submits 510(K) To FDA For Its Innovative 5-FU CVC 5FreshDirect's Fleet Goes Biodiesel 2FreshDirect's Fleet Goes Biodiesel 3
(Date:5/21/2013)... "place" is increasingly being considered in the management ... new resource that can help them recognize and ... places in their lives. , Place-Based Conservation: ... co-edited by the Pacific Northwest Research Station,s Linda ... to conservation. The book is published by Springer ...
(Date:5/21/2013)... When infections occur in the body, stem cells ... multiplying and differentiating into mature immune cells that ... inflammation can deplete these cell populations, potentially leading ... as cancer. Now, a team of researchers led ... (Caltech) has found that, in mouse models, the ...
(Date:5/21/2013)... University researchers have developed a new method for ... holes in the cell surface. The technique could ... related biological fields. , Bulk electroporation a ... reversible nanopores in the cell membrane that are ... is an increasingly popular method of cell transfection. ...
Breaking Biology News(10 mins):Keeping stem cells strong 2Single-cell transfection tool enables added control for biological studies 2
... a result of increasing levels of atmospheric carbon ... according to Michael Maguire presenting at the Society ... week. Postgraduate researcher Mr Maguire, together with ... they simulated ocean acidification as predicted by current ...
... factors instrumental in triggering latent tuberculosis (TB) infection to ... researchers. New insight into the mystery is provided by ... Microbiology,s spring meeting in Edinburgh today. His work could ... Professor Russell and his group at Cornell University in ...
... surroundings by detecting hormone signals from the host, which ... hormonal messages could be a better way to treat ... good, explains Vanessa Sperandio speaking at the Society for ... bacteria, including harmful strains of Escherichia coli ...
Cached Biology News:Fat clue to TB awakening 2'Hormone therapy' for food poisoning bacteria 2
... CellBIND surface is produced by a patented ... surface giving more consistent, even cell attachment, ... cell attachment and growth uunder difficult conditions, ... CellBIND may provide a more ecominic alternative ...
Mouse polyclonal antibody raised against a partial recombinant RDH5. NCBI Entrez Gene ID = 5959...
The Discovery Series PDQuest 2-D analysis software is used for imaging, analyzing, and databasing two-dimensional electrophoretic gels. The version upgrade allows upgrade of an established version of...
Mouse monoclonal antibody raised against a partial recombinant MYO7A. NCBI Entrez Gene ID = MYO7A...
Biology Products: